US moves a step closer to expanding Covid vaccinations for millions more children as a panel of government advisers endorses kid-size doses of Pfizer's shots for 5- to 11-year-olds
Heather Haworth, left, holds the hand of her 12-year-old son Jeremy as he receives the first dose of the Pfizer vaccine in Santa Ana, California on May 13, 2021.
"It is pretty clear to me that the benefits do outweigh the risk when I hear about children who are being put in the ICU, who are having long term outcomes after their Covid, and children are dying," said Amanda Cohn of the Centers of Disease Control and Prevention , who voted yes. Earlier, top FDA vaccine scientist Peter Marks said younger children were "far from being spared harm of Covid-19," adding that, in this group, there had been 1.9 million infections and 8,300 hospitalisations, roughly a third of which required intensive care.Rare side-effects
If community transmission was brought down to very low levels, this may change –– but even then vaccination might be worthwhile because of long term risks linked to non-hospitalized cases, she added. There were no cases of myocarditis or pericarditis , but experts agreed there were not enough study volunteers to be able to detect highly rare side-effects.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
U.S. FDA advisers weigh Pfizer/BioNTech COVID-19 vaccine in childrenAn expert panel will weigh authorization of Pfizer Inc and BioNTech's COVID-19 vaccine for U.S. children aged 5 to 11 on Tuesday as it prepares to vote on a recommendation for the federal Food and Drug Administration.
続きを読む »
Covid: FDA officials back Pfizer jab for children over five in USHealth experts say the benefits outweigh the risks and recommend the FDA authorise the vaccine.
続きを読む »
COVID-19 live updates: FDA panel hours away from vote on Pfizer vaccine for kidsAn independent FDA advisory panel will debate and vote on whether to authorize the Pfizer vaccine for children ages 5 to 11. The nonbinding vote is expected between 4:30 p.m. and 5 p.m. ET today.
続きを読む »
Pfizer CEO says company will produce 4 billion COVID-19 doses in 2022Pfizer CEO Albert Bourla says the company is increasing its output to meet global demand.
続きを読む »
U.S. COVID-19 Cases Continue to Fall, Though Some Hot Spots RemainCOVID-19 cases have been declining in every region of the U.S., marking a 57% drop since the peak on Sept. 1, according to The New York Times.
続きを読む »